Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons - News | Philips
FDA adcom to pronounce on paclitaxel-coated devices | Evaluate
Profitable Strategic Report on Peripheral Drug-Coated Balloon
Spectranetics scores CE mark for PAD drug-coated balloon | Fierce Biotech
Stellarex Drug-coated 0.035" angioplasty balloon | Philips
Stellarex Drug-coated 0.035" angioplasty balloon | Philips
Stellarex Drug-coated 0.035" angioplasty balloon | Philips
Stellarex Drug Coated Angioplasty Balloons – Vascupedia
Drug-Eluting Balloon Market Size & Share | Report 2022, 2027
Stellarex Drug-coated 0.035" angioplasty balloon | Philips
Drug-Eluting Balloon Marktanteil, Größe | 2022-27 | Tendenzen
Drug-Coated Balloons Market - Global Outlook and Forecast 2020-2025
Latest data from Philips reinforces the safety profile of Stellarex low-dose DCB - Vascular News
Drug-coated balloons: Technical and clinical progress - Huiying Ang, Tobias R Koppara, Salvatore Cassese, Jaryl Ng, Michael Joner, Nicolas Foin, 2020
Stellarex Drug-coated 0.035" angioplasty balloon | Philips
Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease - ScienceDirect
U.S. Drug-Coated Balloons Market Threatened by Reimbursement Cuts and | mddionline.com
Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review | Journal of the American College of Cardiology
Stellarex Drug-coated 0.035" angioplasty balloon | Philips
Diagnostics | Free Full-Text | The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease - ScienceDirect
Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say | tctmd.com
Stellarex Drug-coated 0.035" angioplasty balloon | Philips
Peripheral Artery Disease Treatment: Paclitaxel & Sirolimus | VER Journal
FDA Okays Two Stellarex DCBs for Peripheral Artery Disease
